Dr Reddy’s launch generic Namenda in US markets

  • Posted on: 20 July 2015
  • By: Shalini.Sharma

GPAT courses

Pharma courses

pharma courses

pharma courses

Dr Reddy’s Laboratories has launched the United States Food & Drug Administration (FDA) approved memantine hydrochloride tablets  USP, 5 mg and 10 mg, a therapeutic equivalent generic version of Namenda (memantine HCl) tablets in the US market on July  12, 2015. Dr Reddy’s Memantine hydrochloride tablets USP, 5 mg is available in bottle count size of 60 and the memantine hydrochloride tablets USP, 10 mg are available in bottle count sizes of 60 and 500.

The Namenda (memantine HCl) tablets brand had US sales of approximately $ 1.4 billion MAT for the most recent twelve months ending in May 2015 according to IMS Health.


Latest News